| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |